A carregar...
The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?
BACKGROUND: High concentrations of recombinant activated factor VII (rFVIIa) can stop bleeding in hemophilic patients. However the rFVIIa dose needed for stopping haemhorrage in off-label indications is unknown. Since thrombin is the main hemostatic agent, this study investigated the effect of rFVII...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2885319/ https://ncbi.nlm.nih.gov/pubmed/20444280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-8-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|